HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miah, S. M. S. Articles by Sada, K. Search for Related Content PubMed PubMed Citation Articles by Miah, S. M. S. Articles by Sada, K.

Division of Proteomics, Department of Genome Sciences, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

Adaptor protein 3BP2 positively regulates the high affinity IgE receptor (FcRI)-mediated activation of degranulation in mast cells. Genetic study identified the point mutations of 3BP2 gene in human-inherited disease cherubism. The multiple cysts in cherubism lesion of jaw bones are filled with the activated osteoclasts and stromal cells, including mast cells. By over-expression study using rat basophilic leukaemia RBL-2H3 mast cells, we have analysed the effect of the point mutations on the function of 3BP2 protein, which plays a positive regulatory role on FcRI-mediated mast cell activation. Over-expression of 3BP2 mutants suppressed the antigen-induced degranulation and cytokine gene transcription. Antigen-induced phosphorylation of Vav1, activation of Rac1, extracellular signal regulated kinase (ERK), c-Jun N-terminal kinase (JNK), p38 mitogen activated protein kinase (MAPK), inhibitor of nuclear factor B kinase (IKK) and nuclear factor of activated T cells (NFAT) were all impaired in the cells over-expressing the cherubism mutants of 3BP2. Furthermore, cherubism mutations of 3BP2 may abrogate the binding ability to interact with chaperone protein 14-3-3. These results demonstrate that over-expression of the mutant form of 3BP2 inhibits the antigen-induced mast cell activation. It suggests that point mutations of 3BP2 gene cause the dysfunction of 3BP2 in vivo.

^* Correspondence: E-mail: ksada{at}med.kobe-u.ac.jp

This article has been cited by other articles:

				U. Shukla, T. Hatani, K. Nakashima, K. Ogi, and K. Sada Tyrosine Phosphorylation of 3BP2 Regulates B Cell Receptor-mediated Activation of NFAT J. Biol. Chem., December 4, 2009; 284(49): 33719 - 33728. [Abstract] [Full Text] [PDF]

				M. A. de la Fuente, L. Kumar, B. Lu, and R. S. Geha 3BP2 Deficiency Impairs the Response of B Cells, but Not T Cells, to Antigen Receptor Ligation Mol. Cell. Biol., July 15, 2006; 26(14): 5214 - 5225. [Abstract] [Full Text] [PDF]

				R. Kurihara, Y. Tohyama, S. Matsusaka, H. Naruse, E. Kinoshita, T. Tsujioka, Y. Katsumata, and H. Yamamura Effects of Peripheral Cannabinoid Receptor Ligands on Motility and Polarization in Neutrophil-like HL60 Cells and Human Neutrophils J. Biol. Chem., May 5, 2006; 281(18): 12908 - 12918. [Abstract] [Full Text] [PDF]

				X. Qu, S. M. S. Miah, T. Hatani, M. Okazaki, N. Hori-Tamura, H. Yamamura, H. Hotta, and K. Sada Selective Inhibition of Fc{varepsilon}RI-Mediated Mast Cell Activation by a Truncated Variant of Cbl-b Related to the Rat Model of Type 1 Diabetes Mellitus J. Biochem., June 1, 2005; 137(6): 711 - 720. [Abstract] [Full Text] [PDF]